PCR-based approaches, such as combining analyses of a combination of mature FDC markers, HEV markers and TLS associated chemokines such as CCL19, CCL21 and CXCL13 [21], could also decrease the chance of missing TLS-positive tumours. Here, CCL19 is linked to neoplasm.